Carvajal Alejandra

CIK 00016457554 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001645755

Recent Transactions

50 trades

Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2026-08-03+450,000→ 450,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2026-08-03+100,000→ 100,000 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,527→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−3,047→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−7,921→ 0 total
Disposition from Tender
Mersana Therapeutics, Inc.$MRSN
Common Stock
2026-01-06−3,131→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,800→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,078→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−717→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−4,922→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−1,500→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−6,702→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−2,166→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−4,500→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−100→ 0 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-16$0.58/sh−5,096→ 78,296 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-15+54,167→ 54,167 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-15$0.63/sh−952→ 70,892 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-15−12,500→ 37,500 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-15+12,500→ 83,392 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (Right to Buy)
2025-01-15+243,750→ 243,750 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-14+2,500→ 71,844 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-14−2,500→ 2,500 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-14$0.66/sh−3,330→ 69,344 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-13−8,958→ 17,917 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-13+8,958→ 72,674 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-03$1.96/sh−5,598→ 63,716 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-02$2.00/sh−8,089→ 69,314 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-01+50,000→ 77,403 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-10-01−50,000→ 0 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-16$2.71/sh−4,381→ 27,403 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-15+50,000→ 50,000 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (Right to Buy)
2024-01-15+225,000→ 225,000 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-14−2,500→ 5,000 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-14+2,500→ 31,784 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-13−8,958→ 26,875 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-13+8,958→ 29,284 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted stock unit
2023-09-05+50,000→ 50,000 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-04-27$3.89/sh−3,944→ 20,326 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted stock unit
2023-04-26−13,250→ 0 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-04-26+13,250→ 24,270 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-01-17$5.74/sh−782→ 11,020 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted stock unit
2023-01-14−2,500→ 7,500 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-01-14+2,500→ 11,802 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted stock unit
2023-01-13+35,833→ 35,833 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock option (right to buy)
2023-01-13+161,250→ 161,250 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2022-04-26+13,250→ 13,250 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2022-04-26$3.69/sh−3,948→ 9,302 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted stock unit
2022-04-26−13,250→ 13,250 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2022-01-14+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov